Clinical trial
The REDIVAC Study-Reducing Delay in Vaccination of Children Study
NCT03516682 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The REDIVAC Study-Reducing Delay in Vaccination of Children Study
- Lead sponsor
- Kaiser Permanente
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2018
- Completion date
- March 31, 2019
- Enrollment
- 250 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
communicable disease